Breaking News

Wed Sep 5, 2012 4:27PM
Iran has invested around 2.5 billion dollars in stem cell research since 2008.

Iran has invested around 2.5 billion dollars in stem cell research since 2008.

I think Iran has [made] quite a number of scientific contributions to both stem cell research and reproductive biomedicine and it’s a really good opportunity to be here and learn more about them." Prof. Paul Tesar, Case Western Reserve University
Iran has held the 8th Congress on Stem Cell Biology and Technology, hosting scientists from nine countries in the capital city of Tehran, Press TV reports. A group of fourteen scientists have participated in the event to discuss the importance of stem cell research and its ability to prevent genetic diseases. Iran has invested around 2.5 billion dollars in stem cell research since 2008 and ranks second in the world in stem cells transplantation. Iran’s Royan Institute for Reproductive Biomedicine, Stem Cell Biology, and Technology is the country’s leading biomedical research center involved in stem cell technology and regenerative medicine. “Royan Institute is one of the top institutes in stem cell research and I guess it’s very good … that the Iranian government invests permanently … in the stem cell research,” Professor Jurgen Hescheler of Cologne University told Press TV. Royan Institute researchers have used stem cell therapy to treat patients with cardiac arrest, chronic lower extremities ulcers, liver cirrhosis, and vitiligo. They have also succeeded in cloning various farm animals, including a lamb named 'Royana', a goat named 'Hanna' and two calves called 'Bonyana' and 'Tamina'. “I think Iran has [made] quite a number of scientific contributions to both stem cell research and reproductive biomedicine and it’s a really good opportunity to be here and learn more about them,” said Prof. Paul Tesar of the Case Western Reserve University, US. Iran has also taken great strides in other scientific sectors including biotechnology, medical science and aerospace research. TE/SS
Comments
Before you submit, read our comment policy. Send your Feedback.
Captcha
500 characters left
Loading ...